MedPath

REBEL DISTRIBUTORS CORP.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

610

FDA:610

Drug Approvals

Escitalopram

Approval Date
Dec 25, 2012
FDA

Methyldopa

Approval Date
Dec 11, 2012
FDA

Ipratropium Bromide

Approval Date
Dec 11, 2012
FDA

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Nov 14, 2012
FDA

Cephalexin

Approval Date
Oct 30, 2012
FDA

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Approval Date
Oct 30, 2012
FDA

Nystatin

Approval Date
Oct 16, 2012
FDA

Lansoprazole

Approval Date
Oct 16, 2012
FDA

NEO-POLYCIN

Approval Date
Sep 26, 2012
FDA

DONEPEZIL HYDROCHLORIDE

Approval Date
Sep 26, 2012
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 61
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.